Journals / MN Oftalmoloji / 2004 / Cilt: 11 - Sayı: 4

The early result of the probing with Mitomycin C for the patient over the age of 60 with the nasolacrimal obstruction

Altmış yaş üzeri nazolakrimal kanal tıkanıklığı olgularında Mitomisin C ile sondalamanın erken dönem sonuçları

Pages
329–331
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Probing should be tried as a first procedure for the old patient, who has systemic problems and difficulties for DCR procedure, because of its simplicity and its success rate of 43.7%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The purpose of the study is to report the early result of probing and lavage of the nasolacrimal canals with the Mitomycin C (MMC) for the patient over the age of 60, who has nasolacrimal canal obstruction.
📊
Key Findings & Data:Material and Methods: Lavage with 0.2 mg/ml with MMC after the probing was applied to 16 patients over the age of 60 with nasolacrimal canal obstruction under the topical anesthesia.
💡
Conclusion & Impact:Probing should be tried as a first procedure for the old patient, who has systemic problems and difficulties for DCR procedure, because of its simplicity and its success rate of 43.7%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mitomisin · Gözyaşı kanalları tıkanması · Nazolakrimal kanal

Abstract

Purpose: The purpose of the study is to report the early result of probing and lavage of the nasolacrimal canals with the Mitomycin C (MMC) for the patient over the age of 60, who has nasolacrimal canal obstruction. Material and Methods: Lavage with 0.2 mg/ml with MMC after the probing was applied to 16 patients over the age of 60 with nasolacrimal canal obstruction under the topical anesthesia. They were examined at the first day, seventh day and then one time in a month. Results: Each patient was over the age of 60 and women. Probing was applied to 13 of 16 eyes (81.2%) succesfully. Probing was failed in 3 of 16 eyes (18.7%). They were followed up for 3 months. At the last visit, it was seen that probing was succesfull at 7 of the 16 eyes (43.7%), but at 6 of 16 eyes (37.5%) nasolacrimal canal obstruction recurred at the different times. There was no complication during the procedure. Conclusion: Probing with MMC is a simple, minimal invasive, noncomplicated procedure for the patients with nasolacrimal canal obstruction. Probing should be tried as a first procedure for the old patient, who has systemic problems and difficulties for DCR procedure, because of its simplicity and its success rate of 43.7%.

Özet

Amaç: Altmış yaş üzeri nazolakrimal kanal (NLK) tıkanıklığı olan olgularda sondalama ve mitomisin C'li (MMC) lavaj uygulamasının erken dönem sonuçlarının sunulması. Gereç ve Yöntem: NLK tıkanıklığı saptanan 60 yaş üzeri 15 hastanın 16 gözüne topikal anestezi altında sondalama işlemi ardından 0.2 mg/ml MMC ile lavaj işlemi uygulandı. İşlem sonrası 1.gün,1 hafta, ardından aylık kontrolleri yapıldı. Bulgular: Tüm hastalar 60 yaş üzeri kadın idi. Onüç (%81.2) gözde sondalama başarı ile uygulandı. Üç (%18.7) olguda sondalama başarısız oldu. Olgular 3 ay takip edildi. Yedi (%43.7) gözde takip süresince lavaj açık kaldı. Altı (%37.5) gözde işlemden sonra değişik zamanlarda tekrar tıkanıklık oluştu. Hiçbir hastada komplikasyon görülmedi. Sonuç: NLK tıkanıklığı olan olgularda MMC'li sondalama prosedürü basit, minimal invaziv ve komplikasyonsuz bir yöntemdir. Sondalama işlemi uygulanması kolay ve %43.7'lik açık kalma oranı göz önüne alındığında, sistemik problemleri olan ve dakriyosistorinostomi operasyonunun uygulanabilme zorluğu olan, özellikle yaşlı hastalarda denenebilir

🔖

Cite This Article

TÜRE, M., KÜÇÜKBAY, S., MADEN, A., ÇAKIR, İ., SAKLAMAZ, A. (2004). The early result of the probing with Mitomycin C for the patient over the age of 60 with the nasolacrimal obstruction. MN Oftalmoloji, Cilt: 11 - Sayı: 4, 329–331. https://ajindex.com/articles/296088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Bartley GB. Acquired lacrimal drainage obstruction:an etiologic classification system, case reports, and a review of the literature. Part 1. (Review) Ophthalmic Plast Reconstr Surg 1992; 8:237-42
  2. Bell TAG. An investigation into the efficacy of probing the nasolacrimal duct as a treatment for epiphora in adults. Trans Ophthalmol Soc UK 1986; 105:494-7
  3. Guinot-Saera A, Koay P. Efficacy of probing as treatment of epiphora in adults with blocked nasolacrimal ducts. Br J Ophthalmol 1998; 82:389-91
  4. Fulcher T, O’Connor M, Moriarty P. Nasolacrimal intubation in adults. Br J Ophthalmol. 1998; 82:1039-41
  5. Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5- fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990; 97:1204-10
  6. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95:813-21
  7. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98:317-21
  8. Wilson MW, Hungerford JL, George SM, Madreperia SA. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997; 124:303-11
  9. Kao SCS, Liao CL, Tseng JHS. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997; 104:86-91
  10. Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 1987; 94:698-705
  11. Chieh-Chih Tsai, Hui-Chan Kau. Efficacy of probing the nasolacrimal duct with adjunctive mitomycin-C for epiphora in adults. Ophthalmology 2002; 109:172-4
  12. Kao SCS, Liao CL, Tseng JHS, et al. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997; 104:86-91
  13. Camara JG, Bengzon AU, Henson RD. The safety and efficacy of mitomycin C in endonasal endoscopic laserassited dacryocystorhinostomy. Ophthalmic Plast Surg 2000; 16:114-8
  14. Yeatts RP, Neves RB. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthalmic Plast Surg 1999; 15:19-22
  15. Ugurbas SH, Zilelioglu G, Sargon MF, et al. Histopathologic effects of mitomycin C on endoscopic transnasal dacryocystorhinostomy. Ophthalmic Surg Lasers 1997; 28:300-4
  16. Rubinfield RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology 1992; 99:1647-54.